Clinical Trials
4 trialsNCT02116712 2016-11-30
The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
Baylor College of Medicine
Phase 1 Completed
NCT00704366 2011-05-16
AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours
AstraZeneca
Phase 1 Completed
NCT00496028 2010-09-22
Phase I Study in Patients With Solid Tumours
AstraZeneca
Phase 1 Completed
NCT00475956 2010-04-15
Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed